CN107375350A - Clear stone Chinese medicine composition and preparation method thereof - Google Patents

Clear stone Chinese medicine composition and preparation method thereof Download PDF

Info

Publication number
CN107375350A
CN107375350A CN201710728427.7A CN201710728427A CN107375350A CN 107375350 A CN107375350 A CN 107375350A CN 201710728427 A CN201710728427 A CN 201710728427A CN 107375350 A CN107375350 A CN 107375350A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
clear stone
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710728427.7A
Other languages
Chinese (zh)
Other versions
CN107375350B (en
Inventor
赵庆春
李昕
马宏达
崔亚玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital of the Northern War Zone of the Chinese People's Liberation Army
Original Assignee
赵庆春
李昕
马宏达
崔亚玲
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 赵庆春, 李昕, 马宏达, 崔亚玲 filed Critical 赵庆春
Priority to CN201710728427.7A priority Critical patent/CN107375350B/en
Publication of CN107375350A publication Critical patent/CN107375350A/en
Application granted granted Critical
Publication of CN107375350B publication Critical patent/CN107375350B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of clear stone Chinese medicine composition, including 200 1600 parts of Lygodium japonicum, 150 1200 parts of pyrrosia lingua, 150 1200 parts of the bark of official magnolia, the Fen , pivots of Poria cocos 200 1600 store 150 1200 parts, 150 1200 parts of oriental wormwood, 200 1600 parts of rhizoma alismatis, 150 1200 parts of fringed pink, 150 1200 parts of rhizoma imperatae, 200 1600 parts of the shell of areca nut, 100 800 parts of 150 1200 parts of the Radix Astragali, 200 1600 parts of the root of three-nerved spicebush and honey-fried licorice root.The invention discloses a kind of preparation method of clear stone Chinese medicine composition, including：Step 1: taking the bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis, medicinal extract is made as；Step 2: the dregs of a decoction in step 1 mix with Lygodium japonicum, pyrrosia lingua, Poria cocos, pivots storage, oriental wormwood, fringed pink, rhizoma imperatae, the shell of areca nut, the Radix Astragali and honey-fried licorice root, medicinal extract is made as, then merges mixing with above-mentioned medicinal extract, obtains clear stone Chinese medicine composition.

Description

Clear stone Chinese medicine composition and preparation method thereof
Technical field
The invention belongs to application in TCM technical field, is related to a kind of clear stone Chinese medicine composition and preparation method thereof.
Background technology
Urolithiasis is urinary system common disease and frequently-occurring disease, wherein kidney stone incidence of disease highest, and 80% is calcinm oxalate calculus. Traditional Chinese medicine thinks：Kidney stone belongs to the category of the illness such as " urolithiasis ", " sand leaching ", " blood strangury ", " pain in the back ".It is clinically to show as urinating more Calcium, oxalic acid, the discharge such as phosphate discharge increase, magnesium ion, citric acid, citric acid reduce, and are often accompanied by blood calcium rise in liquid.Kidney Calculus pathogenic factor and mechanism are more complicated, are the coefficient results such as inherent cause and environmental factor.Research is thought at present, The supersaturation of calcium oxalate is the prerequisite that kidney stone is formed, then a system such as experience nucleation, growth, aggregation and solid phase transformation Row physical and chemical process.Therefore, a kind of medicine of effectively treatment kidney stone is developed, is the problem currently explored.
The content of the invention
It is an object of the invention to solve at least the above and/or defect, and provide at least will be described later it is excellent Point.
It is a still further object of the present invention to provide a kind of clear stone Chinese medicine composition.
It is of the invention separately to there is a purpose to be to provide a kind of preparation method of clear stone Chinese medicine composition.
Therefore, technical scheme provided by the invention is：
A kind of clear stone Chinese medicine composition, including：
Lygodium japonicum 200-1600 parts and pyrrosia lingua 150-1200 parts.
Preferably, described clear stone Chinese medicine composition, the component of following parts by weight is included：
Bark of official magnolia 150-1200 parts, Poria cocos 200-1600 Fen , pivots store 150-1200 parts, oriental wormwood 150-1200 parts, rhizoma alismatis 200- 1600 parts, fringed pink 150-1200 parts and rhizoma imperatae 150-1200 parts.
Preferably, described clear stone Chinese medicine composition, the component of following parts by weight is included：
Shell of areca nut 200-1600 parts, Radix Astragali 150-1200 parts, root of three-nerved spicebush 200-1600 parts and honey-fried licorice root 100-800 parts.
Preferably, in described clear stone Chinese medicine composition, the clear stone Chinese medicine composition includes following parts by weight Component：800 parts of the Lygodium japonicum, 600 parts of pyrrosia lingua, 600 parts of the bark of official magnolia, 600 parts of the Fen , pivots of Poria cocos 800 storage, 600 parts of oriental wormwood, rhizoma alismatis 800 parts, 600 parts of fringed pink, 600 parts of rhizoma imperatae, 800 parts of the shell of areca nut, 600 parts of the Radix Astragali, 400 parts of 800 parts of the root of three-nerved spicebush and honey-fried licorice root.
Preferably, in described clear stone Chinese medicine composition, the clear stone Chinese medicine composition includes the group of following parts by weight Point：
1600 parts of the Lygodium japonicum, 1200 parts of pyrrosia lingua, 1200 parts of the bark of official magnolia, the Fen , pivots of Poria cocos 1600 store 1200 parts, oriental wormwood 1200 Part, 1600 parts of rhizoma alismatis, 1200 parts of fringed pink, 1200 parts of rhizoma imperatae, 1600 parts of the shell of areca nut, 1200 parts of the Radix Astragali 1600 parts of the root of three-nerved spicebush and processs 800 parts of radix glycyrrhizae.
Preferably, in described clear stone Chinese medicine composition, the clear stone Chinese medicine composition includes following parts by weight Component：Lygodium japonicum 400-800 parts, pyrrosia lingua 300-600 parts, bark of official magnolia 300-600 parts, Poria cocos 400-800 Fen , pivots store 300-600 parts, Oriental wormwood 300-600 parts, rhizoma alismatis 400-800 parts, fringed pink 300-600 parts, rhizoma imperatae 300-600 parts, shell of areca nut 400-800 parts are yellow Stilbene 300-600 parts, root of three-nerved spicebush 400-800 parts and honey-fried licorice root 200-400 parts.
Preferably, in described clear stone Chinese medicine composition, the clear stone Chinese medicine composition includes following parts by weight Component：400 parts of Lygodium japonicum, 300 parts of pyrrosia lingua, 300 parts of the bark of official magnolia, 300 parts of the Fen , pivots of Poria cocos 400 storage, 300 parts of oriental wormwood, 400 parts of rhizoma alismatis, 200 parts of 300 parts of fringed pink, 300 parts of rhizoma imperatae, 400 parts of the shell of areca nut, 300 parts of the Radix Astragali, 400 parts of the root of three-nerved spicebush and honey-fried licorice root.
Preferably, in described clear stone Chinese medicine composition, the clear stone Chinese medicine composition is granular preparation, mixture, glue Capsule preparation, pill or tablet, the pill includes extraction medicinal extract pill and former powder is used as medicine pill.
A kind of preparation method of clear stone Chinese medicine composition, comprises the following steps：
Step 1: in terms of parts by weight, the bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis are taken, alcohol reflux is added and extracts 2 hours, filtration, filtrate Recovery ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25；
Step 2: in terms of parts by weight, the dregs of a decoction and Lygodium japonicum, pyrrosia lingua, Poria cocos, pivots storage, the mattress that are filtrated to get in step 1 Old, fringed pink, rhizoma imperatae, the shell of areca nut, the Radix Astragali and honey-fried licorice root mixing, are soaked 2 hours, decoction is secondary, 2 hours every time, decocting liquid Filtration, merges, and concentrate with the filtrate in step 1, lets cool afterwards, and then plus ethanol makes alcohol content stand, filter up to 60%, Filtrate recycling ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25, with the above-mentioned bark of official magnolia, crow Medicine and rhizoma alismatis medicinal extract, which merge, to be mixed, and obtains clear stone Chinese medicine composition；
Wherein, described Lygodium japonicum 200-1600 parts, pyrrosia lingua 150-1200 parts, bark of official magnolia 150-1200 parts, Poria cocos 200-1600 Fen , pivots store 150-1200 parts, oriental wormwood 150-1200 parts, rhizoma alismatis 200-1600 parts, fringed pink 150-1200 parts, rhizoma imperatae 150-1200 Part, shell of areca nut 200-1600 parts, Radix Astragali 150-1200 parts, root of three-nerved spicebush 200-1600 parts and honey-fried licorice root 100-800 parts.
Preferably, in the preparation method of described clear stone Chinese medicine composition, also comprise the following steps：
Step 3: adding dextrin and flavouring into the clear stone Chinese medicine composition, mix, pelletize, dry, particle is made 1000 parts, obtain clear stone particle.
Preferably, in the preparation method of described clear stone Chinese medicine composition, in the step 1, the matter of the ethanol of addition Amount fraction is 40-80%, and addition is 5-10 times of foregoing Chinese medicine weight；
In the step 2, the mass fraction of the ethanol of addition is 50-95%.
Preferably, in the preparation method of described clear stone Chinese medicine composition, in the step 2, before the water of addition is State Chinese medicine weight 5-10 times.
The present invention comprises at least following beneficial effect：
The clear stone Chinese medicine composition of the present invention is by the taste traditional Chinese medicine extraction of pyrrosia lingua, Lygodium japonicum, oriental wormwood, the bark of official magnolia, rhizoma alismatis etc. 13 essence System forms, and has the effect of niter is treating stranguria, cooling blood and relieving pain.In said preparation prescription, Lygodium japonicum inducing diuresis for treating strangurtia analgesic, pyrrosia lingua diuresis is led to Leaching, and energy cooling blood and hemostasis, Lygodium japonicum obtain pyrrosia lingua niter and can stopped blooding, for face lithiasis often with the disease of blood urine, the two niter is treating stranguria, Cooling blood and relieving pain, it is altogether monarch drug in a prescription.Pivot stores inducing diuresis for treating strangurtia and has heat-clearing, oriental wormwood clearing heat and promoting diuresis concurrently, and rhizoma alismatis eliminating dampness and diuresis purges heat, three Make damp and hot from urine to go out；Bark of official magnolia eliminating dampness promoting the circulation of qi, Poria cocos inducing diuresis with bland drug and can invigoration spleen qi, so as to strengthen dampness removing function, fringed pink, Imperata rhizome heat-clearing diuretic, cooling blood and hemostasis, pyrrosia lingua Yu pivots storage, oriental wormwood, the work(of rhizoma alismatis are helped, is altogether ministerial drug.The shell of areca nut, Radix Astragali promoting the circulation of qi profit Urine detumescence, root of three-nerved spicebush promoting qi circulation and relieving pain is adjutant, and three's promoting the circulation of qi is helped below stone, arranges stone and goes out.Radix glycyrrhizae coordinating the drug actions of a prescription, relieving spasm to stop pain are simultaneous Energy heat-clearing, is adjuvant.
Test result indicates that calcium, oxalic acid content significantly reduce in clear each treatment group's nephridial tissue of stone particle, pathological examination result It has been shown that, in kidney calcium oxalate crystal distribution reduce, tubular ectasia, come off, necrosis is obviously improved.Clear stone particle is prompted effectively to press down The formation and promotion calculus discharge of calcinm oxalate calculus processed.Meanwhile urinate Analysis of Biochemical result and show that clear stone particle can be carried significantly High 24h urine volume, promote urine uric acid excretion, alkalized urine.Increase urine volume and alkalized urine can reduce calcium oxalate supersaturation and separate out, and add By force to the souring of urinary tract, calcium oxalate crystals are reduced to the adhesive attraction of renal cells, suppress the formation of calculus.Urine Acid can be combined with calcium oxalate crystals, promote the growth of calcium oxalate crystals.Clear stone particle urinates the excretion of uric acid by increasing, and reduces urine Acid reduces the formation of calcium oxalate crystal to the facilitation of calculus.
Clear stone particle can significantly reduce serum calcium ion, creatinine, urea content, alleviate impaired renal function symptom, improve kidney Bead filtering function, protect renal function.The oxalic acid of high concentration can cause renal cells to produce reactive oxygen species, cause thin Born of the same parents' apoptosis, necrosis and cell membrane surface characteristic changing, promote calculus.Clear stone particle can improve polyphenoils in nephridial tissue SOD level, promote oxalic acid excretion, the damage of renal cells is reduced, so as to suppress the formation of calcium oxalate crystals.
In summary, clear stone particle can effectively reduce calcium in nephridial tissue, oxalic acid content, protect renal cells, promote Enter the excretion of uric acid, alkalized urine, increase urine discharge capacity, so as to suppress the formation of calcinm oxalate calculus.
Meanwhile the present invention combines 1% ethylene glycol using 1% ammonium chloride and replicates kidney calcinm oxalate calculus model.Experimental result table Bright, model control group experimental rat serum calcium, creatinine, urea significantly increase, in nephridial tissue oxalic acid, calcium content and pathological examination with Blank group has significant difference.Represent the success of Rat renal calcinm oxalate calculus model copy.
Further advantage, target and the feature of the present invention embodies part by following explanation, and part will also be by this The research and practice of invention and be understood by the person skilled in the art.
Brief description of the drawings
Fig. 1 is the absorption spectrum curve of catalysing tube and on-catalytic pipe oxalic acid in the one of embodiment of the present invention；
Fig. 2 is the one of embodiment mesoxalic acid canonical plotting of the present invention；
Fig. 3 is calcium ion canonical plotting in the one of embodiment of the present invention；
Fig. 4 is blank control group HE Coloration experiment Rat renals under 400 times of multiplication factors in the one of embodiment of the present invention Dirty tissue micro-image；
Fig. 5 is 400 times of multiplication factor drag control group HE Coloration experiment Rat renals in the one of embodiment of the present invention Dirty tissue micro-image；
Fig. 6 is Shenshitong group HE Coloration experiment rat kidney under 400 times of multiplication factors in the one of embodiment of the present invention Organize micro-image；
Fig. 7 is clear stone particle low dose group HE Coloration experiments under 400 times of multiplication factors in the one of embodiment of the present invention Rat kidney tissue micro-image；
Fig. 8 is clear stone particle middle dose group HE Coloration experiments under 400 times of multiplication factors in the one of embodiment of the present invention Rat kidney tissue micro-image；
Fig. 9 is clear stone particle high dose group HE Coloration experiments under 400 times of multiplication factors in the one of embodiment of the present invention Rat kidney tissue micro-image；
Figure 10 is clear influence block diagram of the stone particle to experimental rat body weight in the one of embodiment of the present invention；
Figure 11 is clear influence block diagram of the stone particle to experimental rat blood calcium in the one of embodiment of the present invention；
Figure 12 is clear influence block diagram of the stone particle to experimental rat creatinine in the one of embodiment of the present invention；
Figure 13 is clear influence block diagram of the stone particle to experimental rat urea in the one of embodiment of the present invention；
Figure 14 is clear influence block diagram of the stone particle to experimental rat urine volume in the one of embodiment of the present invention；
Figure 15 is the influence block diagram that clear stone particle urinates experimental rat pH value in the one of embodiment of the present invention；
Figure 16 is clear influence block diagram of the stone particle to experimental rat urinary calcium in the one of embodiment of the present invention；
Figure 17 is the influence block diagram that clear stone particle urinates experimental rat uric acid in the one of embodiment of the present invention；
Figure 18 is the influence block diagram that clear stone particle urinates experimental rat oxalic acid in the one of embodiment of the present invention；
Influence block diagrams of the Figure 19 for clear stone particle in the one of embodiment of the present invention to experimental rat kidney calcium；
Influence block diagrams of the Figure 20 for clear stone particle in the one of embodiment of the present invention to experimental rat kidney oxalic acid；
Figure 21 is clear influence block diagram of the stone particle to experimental rat SOD in the one of embodiment of the present invention；
Figure 22 is clear influence block diagram of the stone particle to experimental rat Kidney coefficients in the one of embodiment of the present invention.
Embodiment
The present invention is described in further detail below in conjunction with the accompanying drawings, to make those skilled in the art with reference to specification text Word can be implemented according to this.
It should be appreciated that such as " having ", "comprising" and " comprising " term used herein do not allot one or more The presence or addition of individual other elements or its combination.
The present invention provides a kind of clear stone Chinese medicine composition, includes the component of following parts by weight：
Lygodium japonicum 200-1600 parts and pyrrosia lingua 150-1200 parts.
In such scheme, preferably, the clear stone Chinese medicine composition, include the component of following parts by weight：
Bark of official magnolia 150-1200 parts, Poria cocos 200-1600 Fen , pivots store 150-1200 parts, oriental wormwood 150-1200 parts, rhizoma alismatis 200- 1600 parts, fringed pink 150-1200 parts and rhizoma imperatae 150-1200 parts.
In such scheme, preferably, the clear stone Chinese medicine composition, include the component of following parts by weight：
200-1600 parts, Radix Astragali 150-1200 parts, root of three-nerved spicebush 200-1600 parts and honey-fried licorice root 100-800.
In a preferred embodiment, the clear stone Chinese medicine composition includes the component of following parts by weight：
800 parts of the Lygodium japonicum, 600 parts of pyrrosia lingua, 600 parts of the bark of official magnolia, the Fen , pivots of Poria cocos 800 store 600 parts, and 600 parts of oriental wormwood is damp Rush down 800 parts, 600 parts of fringed pink, 600 parts of rhizoma imperatae, 800 parts of the shell of areca nut, 600 parts of the Radix Astragali, 400 parts of 800 parts of the root of three-nerved spicebush and honey-fried licorice root.
In a preferred embodiment, the clear stone Chinese medicine composition includes the component of following parts by weight：
1600 parts of the Lygodium japonicum, 1200 parts of pyrrosia lingua, 1200 parts of the bark of official magnolia, the Fen , pivots of Poria cocos 1600 store 1200 parts, oriental wormwood 1200 Part, 1600 parts of rhizoma alismatis, 1200 parts of fringed pink, 1200 parts of rhizoma imperatae, 1600 parts of the shell of areca nut, 1200 parts of the Radix Astragali 1600 parts of the root of three-nerved spicebush and processs 800 parts of radix glycyrrhizae.
In some preferred embodiments, the clear stone Chinese medicine composition includes the component of following parts by weight：Lygodium japonicum 400-800 parts, pyrrosia lingua 300-600 parts, bark of official magnolia 300-600 parts, Poria cocos 400-800 Fen , pivots store 300-600 parts, oriental wormwood 300-600 Part, rhizoma alismatis 400-800 parts, fringed pink 300-600 parts, rhizoma imperatae 300-600 parts, shell of areca nut 400-800 parts, Radix Astragali 300-600 parts, Root of three-nerved spicebush 400-800 parts and honey-fried licorice root 200-400 parts.
In a preferred embodiment, the clear stone Chinese medicine composition includes the component of following parts by weight：Lygodium japonicum 400 parts, 300 parts of pyrrosia lingua, 300 parts of the bark of official magnolia, 300 parts of the Fen , pivots of Poria cocos 400 storage, 300 parts of oriental wormwood, 400 parts of rhizoma alismatis, 300 parts of fringed pink, 200 parts of 300 parts of rhizoma imperatae, 400 parts of the shell of areca nut, 300 parts of the Radix Astragali, 400 parts of the root of three-nerved spicebush and honey-fried licorice root.
In some preferred embodiments, the clear stone Chinese medicine composition be granular preparation, mixture, capsule preparations, pill or Tablet, the pill includes extraction medicinal extract pill and former powder is used as medicine pill.Can with sugaring can not also sugaring, particle system is made Agent.
The present invention also provides a kind of preparation method of clear stone Chinese medicine composition, comprises the following steps：
Step 1: in terms of parts by weight, the bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis are taken, alcohol reflux is added and extracts 2 hours, filtration, filtrate Recovery ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25；
Step 2: in terms of parts by weight, the dregs of a decoction and Lygodium japonicum, pyrrosia lingua, Poria cocos, pivots storage, the mattress that are filtrated to get in step 1 Old, fringed pink, rhizoma imperatae, the shell of areca nut, the Radix Astragali and honey-fried licorice root mixing, are soaked 2 hours, decoction is secondary, 2 hours every time, decocting liquid Filtration, merges, and concentrate with the filtrate in step 1, lets cool afterwards, and then plus ethanol makes alcohol content stand, filter up to 60%, Filtrate recycling ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25, with the above-mentioned bark of official magnolia, crow Medicine and rhizoma alismatis medicinal extract, which merge, to be mixed, and obtains clear stone Chinese medicine composition；
Wherein, described Lygodium japonicum 200-1600 parts, pyrrosia lingua 150-1200 parts, bark of official magnolia 150-1200 parts, Poria cocos 200-1600 Fen , pivots store 150-1200 parts, oriental wormwood 150-1200 parts, rhizoma alismatis 200-1600 parts, fringed pink 150-1200 parts, rhizoma imperatae 150-1200 Part, shell of areca nut 200-1600 parts, Radix Astragali 150-1200 parts, root of three-nerved spicebush 200-1600 parts and honey-fried licorice root 100-800 parts.
In a preferred embodiment, the preparation method of the clear stone Chinese medicine composition also comprises the following steps：
Step 3: adding dextrin and flavouring into the clear stone Chinese medicine composition, mix, pelletize, dry, particle is made 1000 parts, obtain clear stone particle.
In a preferred embodiment, in the step 1, the mass fraction of the ethanol of addition is 40-80%, is added Measure as 5-10 times of foregoing Chinese medicine weight；
In the step 2, the mass fraction of the ethanol of addition is 50-95%.
In a preferred embodiment, in the step 2, the water of addition is 5-10 times of foregoing Chinese medicine weight.
To make those skilled in the art more fully understand the present invention, examples below is now provided and illustrated.
Embodiment 1
【Effect experiment】
1.1 experiment material
1.1.1 experimental animal
SD rats：Cleaning grade, body weight 180-200g, male, health, the long-living Bioisystech Co., Ltd in Liaoning is purchased from, closed Lattice card number：SCXK (the Liao Dynasty) 2015-0001.
1.1.2 medicine and reagent
Wherein, the prescription of clear stone particle is as follows：
【Low dosage prescription】
【Middle dosage prescription】
【High dose prescription】
1.1.3 key instrument
1.2 experimental method
1.2.1 the foundation and packet of rat model
Healthy male SD rat 48, body weight 180-200g, after adaptability is fed 1 week, sky is divided into using random number method White control group, model control group, Shenshitong Zu, Cheongju stone particle low dose group, middle dose group, high dose group, every group 8.Except sky White remaining outer each group of control group gives 1% ethylene glycol free water, 1% ammonium chloride 2mL/d gavages.After modeling 1 week, Shenshitong Group, Cheongju stone particles low dose group, middle dose group, high dose group are respectively according to 2.7g/kg, 2.25g/kg, 4.5g/kg, 9.0g/kg Gastric infusion, 2 times/day.Model control group, blank control group give the distilled water gavage of equivalent, give modeling while administration Medicine, continuous gavage 3 weeks.
1.2.2 the collection and detection of sample
1.2.2.1 collection and the index analysis of urine specimen：Experiment terminates the previous day collection rat 24h urine and (added anti- Rotten agent), for determining 24h urine volume, urine pH value, urine oxalic acid, urine Ca2+.Automatic biochemical analyzer measure urine Ca2+, colorimetric method for determining Urinate oxalic acid.
1.2.2.2 collection and the index analysis of serum specimen：After modeling 4 weeks, the chloraldurate (matter of rats by intraperitoneal injection 10% Measure fraction), after of flaccid muscles, abdominal vein punctures and takes blood about 5ml, injects centrifuge tube, stands 30 minutes, 3000r/min from Heart 15min, extracts serum specimen, and -20 DEG C of preservations are to be measured.
1.2.2.3 the collection of kidney sample and index analysis：After rat extracting blood, double kidneys are completely cut immediately, separate kidney quilt Film, normal saline flushing is wiped dry, weighs, left kidney be put into 10% neutral formalin (volume fraction) solution it is fixed, for doing HE dyes Color is cut into slices, and the formational situation and Pathological of optical microphotograph Microscopic observation calcium oxalate crystal change；Right kidney is put into -70 DEG C of low temperature Preserved in refrigerator, for determining Ca in Kidney coefficients, nephridial tissue2+, SOD and oxalic acid content.
1.2.2.4 Indexs measure analysis method
1. general status is observed：Observe the change of rat body weight, mental status, amount of drinking water, food-intake and mode of appearance Etc. index, and record at any time.
2. blood biochemistry detects：With automatic clinical chemistry analyzer measure serum urea, creatinine, Ca2+It is horizontal.
3. urinate biochemistry detection：Urine Ca is determined with automatic clinical chemistry analyzer2+, uric acid.
4. renal tissue and oxalate crystal growth in healthy urine content：Using catalytic spectrophotometric nephridial tissue and oxalate crystal growth in healthy urine content.
5. Ca in renal tissue2+Content：Using methyl thymol blue (MTB) colorimetric method for determining Ca2+Content.
6. SOD contents in renal tissue：SOD kits (WST-1 methods).
7. Pathological is cut into slices：The formational situation and Pathological of optical microphotograph Microscopic observation calcium oxalate crystal change.
Wherein, renal tissue and oxalate crystal growth in healthy urine content use catalytic spectrophotometric, autogamy solvent, grope test bar Feasible oxalic acid content assay method is stablized in part, foundation, and specific content of the test is as follows：
1.2.2.4.1 the measure of oxalate crystal growth in healthy urine and nephridial tissue medium-height grass acid content
Experiment uses the content of catalytic spectrophotometric oxalate crystal growth in healthy urine.In acid condition, oxalic acid can be catalyzed potassium chromate Oxidation methyl is red, generates colourless product, and reaction equation is as follows：
Fading rate is represented by：
Using fixed time, under certain condition, the concentration of oxalic acid is directly proportional to the absorbance change of reaction system, this For the basis of catalytic spectrophotometric oxalic acid.
Concrete operation method is as follows：
Each pipe operating method of table 1
Returned to zero instrument with distilled water, after 15min, each pipe adds 1.0mmol/L ZrOCl2·8H2O 1.0mL, shake up, Terminating reaction.Determine absorbance, catalysing tube As, on-catalytic pipe is A0。
1.2.2.4.1.1 the determination of maximum absorption wavelength
Two 15mL tool plug test tubes are taken respectively as catalysing tube (S) and on-catalytic pipe (B), according to above-mentioned catalytic reaction method Operation, length scanning is carried out in 400nm-700nm.As a result Fig. 1 is seen.As a result show, reaction system has maximum suction at 519nm Receive, determine a length of 519nm of maximum absorption wave.
1.2.2.4.1.2 linear relationship is investigated
Precision weighs that oxalic acid is appropriate, and the stock solution that concentration is 1mmoL/L is made.It is appropriate that precision measures stock solution, dilute respectively Release to the solution that concentration is 2,4,8,12,16,20 μm of oL/L, operated according to catalytic reaction method, absorbance is recorded, with concentration (μm ol/L) is abscissa, lg (A0/ A) it is ordinate, try to achieve regression equation：Y=0.00390x+0.01054, r2=0.9993. Result of the test shows, oxalic acid in the range of 0-20 μm of ol/L with lg (A0/ A) there is good linear relationship.Result of the test is shown in Table 2, Fig. 2.
The oxalic acid standard curve of table 2
1.2.2.4.1.3 stability test
2 15mL tool plug test tubes are taken, as catalysing tube (S) and on-catalytic pipe (B), are operated according to catalytic reaction method, point Not 0 after preparation, 10,20,30,40,50,60min determine the absorbance of each pipe, the RSD for measuring catalysing tube absorbance is 0.880%, the RSD of on-catalytic pipe absorbance is 0.619%, illustrates that reaction system is stable in 1 hour, the results are shown in Table 3.
The catalysing tube of table 3 is investigated with on-catalytic pipe color stability
1.2.2.4.1.4 precision test
10 μm of ol/L oxalic acid solution is taken, is operated according to catalytic reaction method, METHOD FOR CONTINUOUS DETERMINATION 6 times, records absorbance, is surveyed The RSD for obtaining absorbance is 0.611% (n=6), meets the requirements, the results are shown in Table 4.
The precision test of table 4
1.2.2.4.1.5 recovery test
6 parts of urine sample for having predicted oxalic acid content is taken, precision measures 0.50mL, is separately added into sodium oxalate reference substance solution 0.50mL, rate of recovery need testing solution is made, with reference to catalytic reaction method, determination sample medium-height grass acid content, is calculated back respectively Yield, as a result oxalic acid average recovery rate is that 101.3%, RSD is 0.858% (n=6), meets the requirements, the results are shown in Table 5.
The rate of recovery data of table 5
1.2.2.4.1.6 urine specimen and nephridial tissue medium-height grass acidity test
Urine pre-treating method：Urine sample 1.5mL is taken, adds activated carbon 0.25g, is decolourized, 10000r/min centrifugation 10min, Filtration, 100 times of dilution are standby.Urine sample medium-height grass acid content is measured according to catalytic reaction operating method.
Renal tissue pre-treating method：Nephridial tissue is taken, it is accurately weighed, add hydrochloric acid：Ethanol：Water (34:120:46) solution 8mL, homogenate, 48h is stood, 3500r/min centrifuges 20min, and Aspirate supernatant is standby.With reference to oxalate crystal growth in healthy urine assay side Method, determine nephridial tissue medium-height grass acid content.
1.2.2.4.2 SOD measure in nephridial tissue
Nephridial tissue is taken, it is accurately weighed, according to weight (g)：Volume (mL)=1:9 ratio adds the physiology salt of 9 times of volumes Water, shreds tissue, and ice-water bath prepares tissue homogenate, 3000r/min centrifugation 10min, takes supernatant.According to SOD kit sides Method operates, and determines protein concentration, SOD inhibiting rates in supernatant, calculates SOD vigor.
1.2.2.4.3 the measure of calcium ion content in nephridial tissue
1.2.2.4.3.1 measuring principle
Calcium In Tissues ion combines in alkaline solution with methyl thymol blue (MTB), generates blue complex.Pass through Colorimetric can calculate the content of calcium compared with the standard calcium equally handled.
1.2.2.4.3.2 operating method, as shown in table 6.
The calcium of table 6 determines operating method
Mix, after standing 5min, 610nm, 1cm optical paths, distilled water zeroing, determine each pipe absorbance.
Calculation formula：
1.2.2.4.3.3 the range of linearity
With reference to 2.2.2.4.3.2 operating methods, calcium ion canonical plotting is as shown in figure 3, standard calcium curve data such as table 7 It is shown, the calcium solution of various concentrations is separately added into, determines its absorbance.As a result show in the range of 0-5mmol/L, absorbance A There is good linear relationship with calcium solution concentration.
The standard calcium curve data of table 7
1.3 statistical analysis technique
Experimental data is represented with mean ± standard deviation (± S), is handled using the statistical softwares of SPSS 22.0, and t- is used between group Inspection is compared, P<0.05 expression difference has statistical significance, P<0.01 thinks with significant difference.
1.4 experimental result
1.4.1 ordinary circumstance observes result
Without animal dead in experimentation.Model control group Hair of Rats is not flourish, matt, and tired mind, activity subtracts It is few.Shenshitong group and the basic, normal, high dosage group hair color of clear stone particle are fair and clear, glossy, mental status, and diet activity is normal. After experiment, model control group body weight reduces (P compared with blank control group body weight conspicuousness<0.01), Shenshitong group, clear stone particle it is low, Middle and high dosage group body weight increases in various degree compared with model control group, and difference has statistical significance (P<0.05).(it is shown in Table 8, figure 10)
Influence of the clear stone particle of table 8 to experimental rat body weight
Note：* the P compared with blank control group is represented<0.05, * * represents the P compared with blank control group<0.01, # expression and mould Type control group compares P<0.05, ## represents the P compared with model control group<0.01.
1.4.2 blood biochemistry analysis result
Each group experimental rat blood biochemistry analysis result is shown in Table 9.Compared with blank control group, model control group urea BU, Cr, Significantly rise (P<0.01)；Compared with model control group, Shenshitong group rat blood serum urea substantially reduces (P<0.05), serum flesh Acid anhydride declines unobvious.Clear basic, normal, high dosage group serum BU, Cr of stone particle significantly reduces (P compared with model control group<0.01).With Blank control group is compared, model control group Ca2+Significantly rise (P<0.01), Shenshitong group, the clear basic, normal, high dosage group of stone particle Ca2+(P is significantly reduced compared with model control group<0.01).(being shown in Table 9, Figure 11~Figure 13)
Influence of the clear stone particle preventing and treating administration of table 9 to calculus blood biochemistry of rats
Note：* the p compared with blank group is represented<0.05, * * represents the p compared with blank group<0.01, # expression and model control group Compare p<0.05, ## represents the p compared with model group<0.01.
1.4.3 biochemical studies are urinated
Each group experimental rat urine biochemical studies are shown in Table 10.Compared with blank control group, model control group 24h urine volume, Urinary calcium, urine oxalic acid significantly raise (P<0.05) pH value, is urinated, urine uric acid significantly reduces (P<0.01)；Compared with model control group, kidney The logical group rat 24h urine volume of stone, urine pH value dramatically increase (P<0.05) it is not notable, to urinate uric acid increase, urine oxalic acid, urinary calcium significantly reduce (P<0.01).The basic, normal, high dosage group 24h urine volume of stone particle, urine pH value, urine uric acid dramatically increase compared with model control group clearly, urinate Oxalic acid, urinary calcium reduce.(P<0.05).(being shown in Table 10, Figure 14~Figure 18)
The clear stone particle preventing and treating administration of table 10 is to the biochemical influence of calculus rat urine
Note：* the p compared with blank group is represented<0.05, * * represents the p compared with blank group<0.01, # expression and model control group Compare p<0.05, ## represents the p compared with model group<0.01
1.4.4 calcium, oxalic acid, SOD measurement results in Kidney coefficients and nephridial tissue
As a result show：Model control group Kidney coefficients significantly raise (P compared with blank control group<0.01), Shenshitong group, clear stone The basic, normal, high dosage group Kidney coefficients of particle have different degrees of reduction (P compared with model control group<0.05).Nephridial tissue super oxygen Thing mutase measurement result represents that model control group SOD significantly reduces (P compared with blank control group<0.01), Shenshitong group, clear stone The basic, normal, high dosage group SOD of particle has different degrees of rise (P compared with model control group<0.05).Model control group nephridial tissue Interior calcium contains, oxalic acid content significantly rise (P compared with blank control group<0.01), calcium, oxalic acid contain in remaining each treatment group's nephridial tissue Amount has different degrees of reduction.(being shown in Table 11, Figure 19~Figure 22)
Influence of the clear stone particle preventing and treating administration of table 11 to calculus renal tissues of rats
Note：* the p compared with blank group is represented<0.05, * * represents the p compared with blank group<0.01, # expression and model control group Compare p<0.05, ## represents the p compared with model group<0.01.
1.4.5 Pathological inspection result
Blank control group experimental rat renal tissue structure is normal, epithelial cell marshalling, rule, has no expansion, becomes Property oedema and calcium oxalate crystal distribution.Model control group rat kidney tissue cortex, medullary substance boundary are unintelligible；Epithelial cell is presented Swelling, the denaturation of height；Lumen shape is irregular, and intracavitary is visible to be dispersed in or connect sheet of calcium oxalate crystals aggregation and sphacelus Matter, visible a large amount of acute, the chronic inflammatory cell infiltrations of interstitial.It is epithelial cell swelling in Shenshitong group rat kidney tissue, bad Extremely improve to a certain degree, calcium oxalate crystal distribution is reduced, and acute, chronic inflammatory cell infiltration occurs in part interstitial.Clear stone It is accidental in Li Ge treatment groups rat kidney tissue to be dispersed in calcium oxalate crystal, cortex, medullary substance distinct；Epithelial cell is substantially without swollen Swollen, tube chamber marshalling, interstitial is acute, chronic cell infiltration significantly mitigates compared with model control group.Clear stone particle is basic, normal, high Obvious difference is not presented for dosage group.(see Fig. 4~Fig. 9)
1.5 conclusions are with discussing
Urolithiasis is urinary system common disease and frequently-occurring disease, wherein kidney stone incidence of disease highest, and 80% is calcinm oxalate calculus. Clinically calcium in urine, oxalic acid, the phosphate of showing as are discharged the discharges such as increase, magnesium ion, citric acid, citric acid and reduced more, and It is often accompanied by blood calcium rise.Kidney stone pathogenic factor and mechanism are more complicated, are that inherent cause and environmental factor etc. are coefficient As a result.The pathogenesis and reason for meeting the animal model of mankind's kidney stone pathogenic process to illustrating kidney stone are established, searching has The therapeutic scheme of effect is significant.Research is thought at present, and the supersaturation of calcium oxalate is the prerequisite that kidney stone is formed, and By going through nucleation, growth, aggregation and a series of physical chemical process such as solid phase transformation.By increasing the intake of ethylene glycol, Increase metabolism generation and the content of oxalate crystal growth in healthy urine of internal oxalic acid, promote the supersaturation of calcium oxalate.Ammonium chloride has kidney malicious Property, can induced renal damage renal cells, cause its necrosis, come off, the formation for crystallization provides nucleus and is calcium oxalate The adhesion of crystal provides condition.Meanwhile ammonium chloride can be acidified urine, promote the supersaturation of calcium oxalate.This experiment uses 1% chlorine Change ammonium and combine 1% ethylene glycol duplication kidney calcinm oxalate calculus model.Test result indicates that model control group experimental rat serum calcium, Creatinine, urea significantly increase, and oxalic acid, calcium content and pathological examination and blank group have significant difference in nephridial tissue.Represent big The success of mouse kidney calcinm oxalate calculus model copy.
Traditional Chinese medicine thinks：Kidney stone belongs to the category of the illness such as " urolithiasis ", " sand leaching ", " blood strangury ", " pain in the back ".Clinical multilist Now for the short puckery, sound of rain pattering shouting pain of urine frequency, dripping notably sediment outflow stone etc. is primary symptom not to the utmost, how touching the course of disease is repeatedly.Clear stone particle by The taste traditional Chinese medicine extraction of pyrrosia lingua, Lygodium japonicum, oriental wormwood, the bark of official magnolia, rhizoma alismatis etc. 13 is refined to be formed, the work(of cooling blood and relieving pain treating stranguria with niter Effect.In said preparation prescription, the analgesic of Lygodium japonicum inducing diuresis for treating strangurtia, pyrrosia lingua inducing diuresis for treating strangurtia, and energy cooling blood and hemostasis, Lygodium japonicum obtain pyrrosia lingua niter And can stop blooding, for face lithiasis often with the disease of blood urine, the two niter is treating stranguria, cooling blood and relieving pain, is altogether monarch drug in a prescription.It is simultaneous that pivot stores inducing diuresis for treating strangurtia There are heat-clearing, oriental wormwood clearing heat and promoting diuresis, rhizoma alismatis eliminating dampness and diuresis purges heat, and three makes damp and hot from urine to go out；Bark of official magnolia eliminating dampness promoting the circulation of qi, Fu Siberian cocklebur inducing diuresis with bland drug and can invigoration spleen qi, so as to strengthen dampness removing function, fringed pink, imperata rhizome heat-clearing diuretic, cooling blood and hemostasis, help pyrrosia lingua with Pivot storage, oriental wormwood, the work(of rhizoma alismatis, it is altogether ministerial drug.The shell of areca nut, Radix Astragali promoting the circulation of qi inducing diuresis to remove edema, root of three-nerved spicebush promoting qi circulation and relieving pain are adjutant, San Zhehang Gas is helped below stone, is arranged stone and is gone out.Radix glycyrrhizae coordinating the drug actions of a prescription, relieving spasm to stop pain, and energy heat-clearing, are adjuvant.
Test result indicates that calcium, oxalic acid content significantly reduce in clear each treatment group's nephridial tissue of stone particle, pathological examination result It has been shown that, in kidney calcium oxalate crystal distribution reduce, tubular ectasia, come off, necrosis is obviously improved.Clear stone particle is prompted effectively to press down The formation and promotion calculus discharge of calcinm oxalate calculus processed.Meanwhile urinate Analysis of Biochemical result and show that clear stone particle can be carried significantly High 24h urine volume, promote urine uric acid excretion, alkalized urine.Increase urine volume and alkalized urine can reduce calcium oxalate supersaturation and separate out, and add By force to the souring of urinary tract, calcium oxalate crystals are reduced to the adhesive attraction of renal cells, suppress the formation of calculus.Urine Acid can be combined with calcium oxalate crystals, promote the growth of calcium oxalate crystals.Clear stone particle urinates the excretion of uric acid by increasing, and reduces urine Acid reduces the formation of calcium oxalate crystal to the facilitation of calculus.
Clear stone particle can significantly reduce serum calcium ion, creatinine, urea content, alleviate impaired renal function symptom, improve kidney Bead filtering function, protect renal function.The oxalic acid of high concentration can cause renal cells to produce reactive oxygen species, cause thin Born of the same parents' apoptosis, necrosis and cell membrane surface characteristic changing, promote calculus.Clear stone particle can improve polyphenoils in nephridial tissue SOD level, promote oxalic acid excretion, the damage of renal cells is reduced, so as to suppress the formation of calcium oxalate crystals.
In summary, clear stone particle can effectively reduce calcium in nephridial tissue, oxalic acid content, protect renal cells, promote Enter the excretion of uric acid, alkalized urine, increase urine discharge capacity, so as to suppress the formation of calcinm oxalate calculus.Its mechanism of action may with it is clear Stone particle can increase mortifier level in urine, reduce calculus promoting factor, increase renal cells anti-oxidation stress It is horizontal relevant.
Embodiment 2
A kind of clear stone particle, include the component of following parts by weight：320 parts of Lygodium japonicum, 240 parts of pyrrosia lingua, 240 parts of the bark of official magnolia, 240 parts of the Fen , pivots of Poria cocos 320 storage, 240 parts of oriental wormwood, 320 parts of rhizoma alismatis, 240 parts of fringed pink, 240 parts of rhizoma imperatae, 320 parts of the shell of areca nut are yellow 160 parts of 240 parts of stilbene, 320 parts of the root of three-nerved spicebush and honey-fried licorice root.
A kind of preparation method of clear stone Chinese medicine composition, comprises the following steps：
Step 1: in terms of parts by weight, the bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis are taken, it is small to add 10 times of amount 70% alcohol reflux extractions 2 When, filtration, filtrate recycling ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25.
Step 2: in terms of parts by weight, the dregs of a decoction and Lygodium japonicum, pyrrosia lingua, Poria cocos, pivots storage, the mattress that are filtrated to get in step 1 Old, fringed pink, rhizoma imperatae, the shell of areca nut, the Radix Astragali and honey-fried licorice root mixing, 10 times of amount water are added to soak 2 hours, decoction is secondary, and 2 is small every time When, decocting liquid filtration, merge with the filtrate in step 1, and concentrate, let cool afterwards, then plus 80% ethanol reaches alcohol content 60%, stand, filtration, filtrate recycling ethanol is simultaneously concentrated into the leaching that relative density at temperature 50 C~55 DEG C is 1.20~1.25 Cream, merge mixing with the above-mentioned bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis medicinal extract.
Step 3: adding dextrin and flavouring into above-mentioned composition, mix, pelletize, dry, sugar-free particle 1000 is made Part, obtain clear stone particle.
Embodiment 3
A kind of clear stone particle, include the component of following parts by weight：480 parts of Lygodium japonicum, 360 parts of pyrrosia lingua, 360 parts of the bark of official magnolia, 360 parts of the Fen , pivots of Poria cocos 480 storage, 360 parts of oriental wormwood, 480 parts of rhizoma alismatis, 360 parts of fringed pink, 360 parts of rhizoma imperatae, 480 parts of the shell of areca nut are yellow 240 parts of 360 parts of stilbene, 480 parts of the root of three-nerved spicebush and honey-fried licorice root.
A kind of preparation method of clear stone Chinese medicine composition, comprises the following steps：
Step 1: in terms of parts by weight, the bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis are taken, 8 times of 40% alcohol refluxs of amount is added and extracts 2 hours, Filtration, filtrate recycling ethanol are simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25.
Step 2: in terms of parts by weight, the dregs of a decoction and Lygodium japonicum, pyrrosia lingua, Poria cocos, pivots storage, the mattress that are filtrated to get in step 1 Old, fringed pink, rhizoma imperatae, the shell of areca nut, the Radix Astragali and honey-fried licorice root mixing, 8 times of amount water are added to soak 2 hours, decoction is secondary, 2 hours every time, Decocting liquid filters, and merges with the filtrate in step 1, and concentrates, and lets cool afterwards, and then plus 50% ethanol makes alcohol content up to 60%, quiet Put, filter, filtrate recycling ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25, and above-mentioned The bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis medicinal extract, which merge, to be mixed.
Step 3: adding dextrin, sugar and flavouring into above-mentioned composition, mix, pelletize, dry, granules of sugar is made 1000 parts, obtain clear stone particle.
Embodiment 4
A kind of clear stone particle, include the component of following parts by weight：
200 parts of Lygodium japonicum, 150 parts of pyrrosia lingua, 150 parts of the bark of official magnolia, 150 parts of the Fen , pivots of Poria cocos 200 storage, 150 parts of oriental wormwood, rhizoma alismatis 200 100 parts of part, 150 parts of fringed pink, 150 parts of rhizoma imperatae, 200 parts of the shell of areca nut, 150 parts of the Radix Astragali, 200 parts of the root of three-nerved spicebush and honey-fried licorice root.
A kind of preparation method of clear stone Chinese medicine composition, comprises the following steps：
Step 1: in terms of parts by weight, the bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis are taken, 5 times of 80% alcohol refluxs of amount is added and extracts 2 hours, Filtration, filtrate recycling ethanol are simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25.
Step 2: in terms of parts by weight, the dregs of a decoction and Lygodium japonicum, pyrrosia lingua, Poria cocos, pivots storage, the mattress that are filtrated to get in step 1 Old, fringed pink, rhizoma imperatae, the shell of areca nut, the Radix Astragali and honey-fried licorice root mixing, 5 times of amount water are added to soak 2 hours, decoction is secondary, 2 hours every time, Decocting liquid filters, and merges with the filtrate in step 1, and concentrates, and lets cool afterwards, and then plus 95% ethanol makes alcohol content up to 60%, quiet Put, filter, filtrate recycling ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25, and above-mentioned The bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis medicinal extract, which merge, to be mixed.
Step 3: adding dextrin and flavouring into above-mentioned composition, mix, pelletize, dry, sugar-free particle 1000 is made Part, obtain clear stone particle.
Although embodiment of the present invention is disclosed as above, it is not restricted in specification and embodiment listed With it can be applied to various suitable the field of the invention completely, can be easily for those skilled in the art Other modification is realized, therefore under the universal limited without departing substantially from claim and equivalency range, it is of the invention and unlimited In specific details and shown here as the legend with description.

Claims (10)

1. a kind of clear stone Chinese medicine composition, it is characterised in that include the component of following parts by weight：
Lygodium japonicum 200-1600 parts and pyrrosia lingua 150-1200 parts.
2. clear stone Chinese medicine composition as claimed in claim 1, it is characterised in that also include the component of following parts by weight：
Bark of official magnolia 150-1200 parts, Poria cocos 200-1600 Fen , pivots store 150-1200 parts, oriental wormwood 150-1200 parts, rhizoma alismatis 200-1600 Part, fringed pink 150-1200 parts and rhizoma imperatae 150-1200 parts.
3. clear stone Chinese medicine composition as claimed in claim 2, it is characterised in that also include the component of following parts by weight：
Shell of areca nut 200-1600 parts, Radix Astragali 150-1200 parts, root of three-nerved spicebush 200-1600 parts and honey-fried licorice root 100-800 parts.
4. clear stone Chinese medicine composition as claimed in claim 3, it is characterised in that the clear stone Chinese medicine composition includes following weight Measure the component of number：Lygodium japonicum 400-800 parts, pyrrosia lingua 300-600 parts, bark of official magnolia 300-600 parts, Poria cocos 400-800 Fen , pivots store 300-600 parts, oriental wormwood 300-600 parts, rhizoma alismatis 400-800 parts, fringed pink 300-600 parts, rhizoma imperatae 300-600 parts, the shell of areca nut 400-800 parts, Radix Astragali 300-600 parts, root of three-nerved spicebush 400-800 parts and honey-fried licorice root 200-400 parts.
5. clear stone Chinese medicine composition as claimed in claim 4, it is characterised in that the clear stone Chinese medicine composition includes following weight Measure the component of number：400 parts of Lygodium japonicum, 300 parts of pyrrosia lingua, 300 parts of the bark of official magnolia, the Fen , pivots of Poria cocos 400 store 300 parts, and 300 parts of oriental wormwood is damp Rush down 400 parts, 300 parts of fringed pink, 300 parts of rhizoma imperatae, 400 parts of the shell of areca nut, 300 parts of the Radix Astragali, 200 parts of 400 parts of the root of three-nerved spicebush and honey-fried licorice root.
6. the clear stone Chinese medicine composition as described in claim 1 to 5 is any, it is characterised in that the clear stone Chinese medicine composition is Granular preparation, mixture, capsule preparations, pill or tablet, the pill includes extraction medicinal extract pill and former powder is used as medicine pill.
7. a kind of preparation method of clear stone Chinese medicine composition, it is characterised in that comprise the following steps：
Step 1: in terms of parts by weight, the bark of official magnolia, the root of three-nerved spicebush and rhizoma alismatis are taken, alcohol reflux is added and extracts 2 hours, filtration, filtrate recovery Ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25；
Step 2: in terms of parts by weight, the dregs of a decoction and Lygodium japonicum, pyrrosia lingua, Poria cocos, pivots storage, oriental wormwood, the Qu that are filtrated to get in step 1 Wheat, rhizoma imperatae, the shell of areca nut, the Radix Astragali and honey-fried licorice root mixing, are soaked 2 hours, and decoction is secondary, 2 hours every time, decocting liquid filtration, Merge with the filtrate in step 1, and concentrate, let cool afterwards, then plus ethanol makes alcohol content be stood, filtration, filtrate up to 60% Recovery ethanol is simultaneously concentrated into the medicinal extract that relative density at temperature 50 C~55 DEG C is 1.20~1.25, with the above-mentioned bark of official magnolia, the root of three-nerved spicebush and Rhizoma alismatis medicinal extract, which merges, to be mixed, and obtains clear stone Chinese medicine composition；
Wherein, described Lygodium japonicum 200-1600 parts, pyrrosia lingua 150-1200 parts, bark of official magnolia 150-1200 parts, Poria cocos 200-1600 Fen , pivots Storage 150-1200 parts, oriental wormwood 150-1200 parts, rhizoma alismatis 200-1600 parts, fringed pink 150-1200 parts, rhizoma imperatae 150-1200 parts, greatly Abdomen skin 200-1600 parts, Radix Astragali 150-1200 parts, root of three-nerved spicebush 200-1600 parts and honey-fried licorice root 100-800 parts.
8. the preparation method of clear stone Chinese medicine composition as claimed in claim 7, it is characterised in that also comprise the following steps：
Step 3: adding dextrin and flavouring into the clear stone Chinese medicine composition, mix, pelletize, dry, particle 1000 is made Part, obtain clear stone particle.
9. the preparation method of clear stone Chinese medicine composition as claimed in claim 7, it is characterised in that in the step 1, add The mass fraction of ethanol be 40-80%, addition is 5-10 times of foregoing Chinese medicine weight；
In the step 2, the mass fraction of the ethanol of addition is 50-95%.
10. the preparation method of clear stone Chinese medicine composition as claimed in claim 7, it is characterised in that in the step 2, add Water be 5-10 times of foregoing Chinese medicine weight.
CN201710728427.7A 2017-08-23 2017-08-23 Traditional Chinese medicine composition for removing calculus and preparation method thereof Active CN107375350B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710728427.7A CN107375350B (en) 2017-08-23 2017-08-23 Traditional Chinese medicine composition for removing calculus and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710728427.7A CN107375350B (en) 2017-08-23 2017-08-23 Traditional Chinese medicine composition for removing calculus and preparation method thereof

Publications (2)

Publication Number Publication Date
CN107375350A true CN107375350A (en) 2017-11-24
CN107375350B CN107375350B (en) 2020-09-15

Family

ID=60354199

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710728427.7A Active CN107375350B (en) 2017-08-23 2017-08-23 Traditional Chinese medicine composition for removing calculus and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107375350B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189267A (en) * 2014-09-15 2014-12-10 曾成锋 Traditional Chinese medicine composition for treating kidney stone and preparation method of traditional Chinese medicine composition
CN104305026A (en) * 2014-09-25 2015-01-28 容瑜 Ferment for inducing decomposition of calculi and its preparation method and use method
CN105434915A (en) * 2015-11-25 2016-03-30 青岛农业大学 Pharmaceutical composition for treating urolithiasis for dogs and cats and preparation method of pharmaceutical composition
KR20160060504A (en) * 2014-11-20 2016-05-30 가톨릭대학교 산학협력단 Composition comprising the extract of Lygodii Spora for preventing and treating calculus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189267A (en) * 2014-09-15 2014-12-10 曾成锋 Traditional Chinese medicine composition for treating kidney stone and preparation method of traditional Chinese medicine composition
CN104305026A (en) * 2014-09-25 2015-01-28 容瑜 Ferment for inducing decomposition of calculi and its preparation method and use method
KR20160060504A (en) * 2014-11-20 2016-05-30 가톨릭대학교 산학협력단 Composition comprising the extract of Lygodii Spora for preventing and treating calculus
CN105434915A (en) * 2015-11-25 2016-03-30 青岛农业大学 Pharmaceutical composition for treating urolithiasis for dogs and cats and preparation method of pharmaceutical composition

Also Published As

Publication number Publication date
CN107375350B (en) 2020-09-15

Similar Documents

Publication Publication Date Title
CN101164585B (en) Medicine for curing gout and its preparing method
CN105687994B (en) A kind of Chinese medicine composition and preparation method thereof for treating chronic renal failure
CN109718257A (en) A kind of Phellinus fruiting body extract and its application in preparation treatment chronic renal failure drug
WO2023109573A1 (en) Traditional chinese medicine composition for treating hashimoto&#39;s thyroiditis, and preparation method therefor
CN102068507A (en) Preparation method of Chinese medicinal capsules for tonifying lung and activating blood circulation
CN1709341B (en) Medicinal composition for nourishing qi to invigorate spleen, and its preparing method and use
CN102068513B (en) Application of coptis astragalus scutellaria composition in preparation of drug for preventing and treating diabetic complication
CN104721467B (en) Traditional Chinese medicine composition for treating diabetic nephropathy and application thereof
CN107375350A (en) Clear stone Chinese medicine composition and preparation method thereof
CN110327434A (en) A kind of Chinese medicine composition that treating gout, compound Chinese medicinal preparation and preparation method thereof
CN101317881A (en) Traditional Chinese medicine compound and formulation for removing renal stone
CN110339252B (en) Traditional Chinese medicine composition for relieving non-alcoholic steatohepatitis and preparation method and product thereof
CN105055967B (en) A kind of complex health care product and preparation method with auxiliary hyperglycemic function
CN104491101B (en) Preparing method of traditional Chinese medicine preparation for treatment of chronic renal failure
CN102755568B (en) Health-care product for assisting in decreasing blood sugar and preparation method thereof
CN102266428A (en) Anti-ageing Chinese medicinal composition and preparation method and application thereof
CN104887766A (en) Traditional Chinese medicine compound capsules for treating atherosclerosis and preparation method thereof
CN101843670B (en) Chinese medicinal composition for clearing heat and detoxicating, promoting urination and treating stranguria
CN100400091C (en) Chinese remedy capsule for treating biliary tract disease
CN110064016A (en) A kind of Chinese medicine composition and preparation method thereof adjusting chronic kidney disease immune state
CN104491102B (en) Colon positioning traditional Chinese medicine preparation for treating chronic kidney failure
CN108888652A (en) A kind of renal lobe beggarweed alcohol extract and its application
CN103446494B (en) Chinese patent medicine for treating Type II diabetic nephropathy and preparation method thereof
CN108210595A (en) Treat Chinese medicine composition of acute-on-chronic liver failure and its preparation method and application
CN107912577A (en) A kind of health protection tea for having effects that to prevent diabetes and preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20190424

Address after: 110016 No. 83, cultural road, Shenhe District, Shenyang, Liaoning

Applicant after: General Hospital of the Northern War Zone of the Chinese People's Liberation Army

Address before: 110016 General Hospital of Shenyang Military Region, 83 Cultural Road, Shenhe District, Shenyang City, Liaoning Province

Applicant before: Zhao Qingchun

Applicant before: Li Cuan

Applicant before: Ma Hongda

Applicant before: Cui Yaling

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant